Metformin Prostate Cancer Adjuvant Trial
Winthrop University Hospital Clinical Trials Center is conducting a clinical research study for men ages 18 and older who have biopsy proven Prostate Cancer.
This study will examine the effect that Metformin Hydrochloride has on Prostate Specific Antigen levels in men with Prostate Cancer.
Metformin therapy for patients diagnosed with Prostate Cancer who have been treated with either radiation therapy or surgery, who have indicators of high risk disease, or who have a rising Prostate Specific Antigen after treatment.
Eligible participants will receive study-related medical examinations, research medication and laboratory tests at no cost, while they are participating in this clinical research study.
To be eligible for this clinical research study you must:
• Be 18 years old
• Be diagnosed with Prostate Cancer
• Have been treated with Radiation Therapy or Surgery
• Not have evidence of metastatic prostate cancer or a diagnosis of Type I Diabetes
Aaron Katz, MD
Winthrop University Hospital Department of Urology
Kaitlin Tietjen Kosinski, BS, MS
Urology Research Coordinator
222 Station Plaza North, Suite 408
Mineola, NY 11501